Table 1 Demographic and clinical data
Demographic and clinical data1 | Patient group treated with haloperidol (n = 30) | Patient group treated with olanzapine (n = 30) |
|---|---|---|
Daily dose (Range) (mg/day) | 19.8 ± 5.6 (2.5–30) | 18.5 ± 3.9 (10–20) |
Age (Range) (yrs) | 29.4 ± 8.1 (19–53) | 26.4 ± 6.19 (18–43) |
BMI2 (Range) (kg/m2) | 23.4 ± 3.76 (17–31.7) | 22.6 ± 4.1 (16.2–35.3) |
Acute psychosis: | ||
Paranoid schizophrenia | 21 (70%) | 14 (46.7%) |
Acute polymorphic psychotic disorder with symptoms of schizophrenia | 9 (30%) | 10 (33.3%) |
Simple type of schizophrenia | – | 1 (3.3%) |
Another type of schizophrenia | – | 1 (3.3%) |
Acute polymorphic psychotic disorder with symptoms of schizophrenia | – | 2 (6.7%) |
Acute schizophrenic disorder | – | 2 (6.7%) |